Adherence to antiretroviral treatment and correlation with risk of hospitalization among commercially insured HIV patients in the United States
about
Switching from twice-daily raltegravir plus tenofovir disoproxil fumarate/emtricitabine to once-daily elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate in virologically suppressed, HIV-1-infected subjects: 48 weeks data.Effect of a smartphone application incorporating personalized health-related imagery on adherence to antiretroviral therapy: a randomized clinical trial.Comparative effectiveness of single versus multiple tablet antiretroviral therapy regimens in clinical HIV practice.Single-Tablet Regimens in HIV TherapyLower healthcare costs associated with the use of a single-pill ARV regimen in the UK, 2004-2008.Cost-effectiveness of genotype testing for primary resistance in BrazilThe clinical role and cost-effectiveness of long-acting antiretroviral therapyProjected Lifetime Healthcare Costs Associated with HIV Infection.Cost-Effectiveness of Single- Versus Generic Multiple-Tablet Regimens for Treatment of HIV-1 Infection in the United States.EPICE-HIV: An Epidemiologic Cost-Effectiveness Model for HIV Treatment.Toxicity and clinical outcomes in patients with HIV on zidovudine and tenofovir based regimens: a retrospective cohort study.Half of 30-Day Hospital Readmissions Among HIV-Infected Patients Are Potentially PreventableEffectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort study.Cost analysis of HIV treatment and drug-related adverse events when fixed-dose combinations of antiretrovirals (FDCs) were stopped, versus continuation with FDCsAntiretroviral therapy in HIV-infected patients: a proposal to assess the economic value of the single-tablet regimen.The Cost-effectiveness and Budget Impact of 2-Drug Dolutegravir-Lamivudine Regimens for the Treatment of HIV Infection in the United States.Cost-effectiveness of CYP2B6 genotyping to optimize efavirenz dosing in HIV clinical practice.Triple-combination rilpivirine, emtricitabine, and tenofovir (Complera™/Eviplera™) in the treatment of HIV infection.Medication Adherence and the Occurrence of Complications in Patients with Newly Diagnosed Hypertension.Association between daily antiretroviral pill burden and treatment adherence, hospitalisation risk, and other healthcare utilisation and costs in a US medicaid population with HIVCorrelates of Combination Antiretroviral Adherence Among Recently Diagnosed Older HIV-Infected Adults Between 50 and 64 yearsEconomic evaluation of initial antiretroviral therapy for HIV-infected patients: an update of Italian guidelines.Measurement of adherence to BCR-ABL inhibitor therapy in chronic myeloid leukemia: current situation and future challenges.Increase in single-tablet regimen use and associated improvements in adherence-related outcomes in HIV-infected women.Combinational therapies for HIV: a focus on EVG/COBI/FTC/TDF.Cobicistat: a new boost for the treatment of human immunodeficiency virus infection.Dolutegravir: a new integrase strand transfer inhibitor for the treatment of HIV.Safety and efficacy of coformulated efavirenz/emtricitabine/tenofovir single-tablet regimen in treatment-naive patients infected with HIV-1.Odds of Viral Suppression by Single-Tablet Regimens, Multiple-Tablet Regimens, and Adherence Level in HIV/AIDS Patients Receiving Antiretroviral Therapy.Adherence to combination antiretroviral treatment and clinical outcomes in a Medicaid sample of older HIV-infected adults.Impact of Cigarette Smoking and Smoking Cessation on Life Expectancy Among People With HIV: A US-Based Modeling Study.Impact of Pill Burden on Adherence, Risk of Hospitalization, and Viral Suppression in Patients with HIV Infection and AIDS Receiving Antiretroviral Therapy.Effectiveness, Safety, and Costs of a Treatment Switch to Dolutegravir Plus Rilpivirine Dual Therapy in Treatment-Experienced HIV Patients.Randomized controlled trial of a pictorial aid intervention for medication adherence among HIV-positive patients with comorbid diabetes or hypertension.The Impact of Substance Use on Adherence to Antiretroviral Therapy Among HIV-Infected Women in the United States.Simplification to single-tablet regimen of elvitegravir, cobicistat, emtricitabine, tenofovir DF from multi-tablet ritonavir-boosted protease inhibitor plus coformulated emtricitabine and tenofovir DF regimens: week 96 results of STRATEGY-PI.Cost-effectiveness analysis of tenofovir/emtricitabine and abacavir/lamivudine in combination with efavirenz or atazanavir/ritonavir for treatment-naïve adults with HIV-1 infection in the UK, based on the AIDS Clinical Trials Group 5202 clinical triLack of clinically important PK interaction between coformulated ledipasvir/sofosbuvir and rilpivirine/emtricitabine/tenofovir alafenamidePharmacokinetics of darunavir after administration of an oral suspension with low-dose ritonavir and with or without food.The financial and service implications of splitting fixed-dose antiretroviral drugs - a case study.
P2860
Q30795793-D71D0478-65E6-4E39-A671-6852F4BA3EE1Q33441775-E37E4DFF-BED5-42EB-8CE3-0290193820E0Q33621206-7A00A139-BCBF-4D76-AA43-6B408C6A4DAAQ33939110-40CEA90B-E394-4A96-9731-A959343AE16EQ34464437-20499108-C961-433F-8A25-FE2420E9D908Q34964120-4DFB5B00-161B-4A4E-821F-6F2C21452FEFQ35197271-52EC07D0-0409-49A0-B37D-CC545D1005F6Q35526724-A1917715-23E5-4E54-9066-875FB92EE7C1Q35903617-302B7D02-636C-49EE-AB44-46CEB19AD219Q35921909-1297FF2A-0924-4866-A67A-7504D2025812Q35975345-F24298CC-6CB3-4168-B49D-898314E8C8E9Q36041402-459D623C-3270-439B-8E32-46E154572201Q36267762-B7506CCF-9B1D-4552-8B4B-52F8A058C016Q36356572-DEB6F80C-58CB-4026-945D-6FCDB3198C8CQ36617684-BEEF812E-8B1E-4CCB-A019-FA7372D69A2CQ36635714-010772C9-D16E-44AE-97CB-64707D8333C8Q36801543-AD469F1F-8183-4D3D-9F9B-3C6EE3BE1E43Q36958229-AC7F7AA2-25DF-4D40-BF94-731D10522B42Q36964650-0622157F-F7C8-417C-BDA4-5AEEC227CB26Q37069682-75E2F65C-49D8-4005-A8EE-7600E3E193ECQ37184269-420FE6BE-6C30-47BF-BCE6-5D3C95D318E3Q37225380-14CE5B14-07DF-418E-8C40-27A37A2FBF63Q37618888-CD5B9CCC-4975-4646-BCFC-78A8261A7D3FQ37722667-8E4AD988-8CC1-4987-8D3C-1FD98B52F863Q38030981-198E387F-977A-4323-8929-EBAF726A2D65Q38087555-57AFD279-3651-4C52-A167-5243276B2F7AQ38172029-FEA09CE6-A053-498D-BA46-0EE45EE295A1Q39016016-56A8186B-B1FE-4FCA-8CF9-E0F66A4EA903Q39060951-E6167F67-A0F6-4E1A-A24B-1822472B4E35Q39148090-3CDDCFDE-F871-4041-B6C0-7B5FDA80FBD5Q39213747-AC590A4C-DC5E-4A19-AA6A-B57D8B4F8D22Q39961994-C9868727-B84D-410D-80A9-FD0C6BB7334DQ40072531-276FC178-9BE4-4CED-8335-CDBDCA9635A5Q40100045-B4A8B999-6F68-4EE6-AB09-F8883A0994E5Q40179664-E882AAEF-718E-4D30-A7E6-9CA0472F1C03Q40194507-96F9CC8E-EF6D-4A8A-AA9F-ECD9A4313308Q40215329-F2BDC047-F08B-41BC-9C8F-E8F527FE7043Q41925730-06A2FA93-E1F1-4B9D-8EEF-744BC3F6ABB9Q42199714-1B2C8267-DE89-4684-A9C4-94797F2CED46Q42226929-E45342C7-F54D-402F-BE35-7301DE851F9C
P2860
Adherence to antiretroviral treatment and correlation with risk of hospitalization among commercially insured HIV patients in the United States
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Adherence to antiretroviral tr ...... patients in the United States
@ast
Adherence to antiretroviral tr ...... patients in the United States
@en
Adherence to antiretroviral tr ...... patients in the United States
@nl
type
label
Adherence to antiretroviral tr ...... patients in the United States
@ast
Adherence to antiretroviral tr ...... patients in the United States
@en
Adherence to antiretroviral tr ...... patients in the United States
@nl
prefLabel
Adherence to antiretroviral tr ...... patients in the United States
@ast
Adherence to antiretroviral tr ...... patients in the United States
@en
Adherence to antiretroviral tr ...... patients in the United States
@nl
P2093
P2860
P921
P1433
P1476
Adherence to antiretroviral tr ...... patients in the United States
@en
P2093
Juliana L Meyers
Keith L Davis
Michael Mugavero
Paul E Sax
P2860
P304
P356
10.1371/JOURNAL.PONE.0031591
P407
P577
2012-02-24T00:00:00Z